Sandy Spring Bank’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62
Closed -$12K 1165
2022
Q1
$12K Hold
62
﹤0.01% 823
2021
Q4
$16K Hold
62
﹤0.01% 810
2021
Q3
$18K Hold
62
﹤0.01% 780
2021
Q2
$12K Hold
62
﹤0.01% 870
2021
Q1
$12K Buy
+62
New +$12.7K ﹤0.01% 761

Other funds holding RGEN

Sandy Spring Bank's RGEN Position: Q2 2022 in Review

Sandy Spring Bank sold out of Repligen (RGEN) in Q2 2022, closing a stake of 62 shares — an estimated $12K sold.

Sandy Spring Bank first reported a position in RGEN in Q1 2021 and held it in 5 quarters. The position peaked at $18K in Q3 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Sandy Spring Bank reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Sandy Spring Bank sold 62 Repligen shares in Q2 2022, an estimated $12K.
  • Sandy Spring Bank first reported a position in Repligen in Q1 2021 and held it in 5 quarters.
  • Sandy Spring Bank's Repligen position peaked at $18K in Q3 2021.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Sandy Spring Bank's 13F filing for Q2 2022, filed 21 Jul 2022.